MA31849B1 - Nouveaux dérivés de pyrimidine - Google Patents
Nouveaux dérivés de pyrimidineInfo
- Publication number
- MA31849B1 MA31849B1 MA32838A MA32838A MA31849B1 MA 31849 B1 MA31849 B1 MA 31849B1 MA 32838 A MA32838 A MA 32838A MA 32838 A MA32838 A MA 32838A MA 31849 B1 MA31849 B1 MA 31849B1
- Authority
- MA
- Morocco
- Prior art keywords
- pyrimidine derivatives
- new pyrimidine
- new
- preparation
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Ophthalmology & Optometry (AREA)
- Dermatology (AREA)
- Rheumatology (AREA)
- Neurosurgery (AREA)
- Obesity (AREA)
- Transplantation (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Emergency Medicine (AREA)
- Pain & Pain Management (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Otolaryngology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
L'invention porte sur de nouveaux dérivés de pyrimidine, sur leur préparation et sur leur utilisation en tant que composés pharmaceutiquement actifs. Lesdits composés agissent particulièrement en tant qu'agents immunomodulants.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IB2007054437 | 2007-11-01 | ||
PCT/IB2008/054543 WO2009057079A2 (fr) | 2007-11-01 | 2008-10-31 | Nouveaux dérivés de pyrimidine |
Publications (1)
Publication Number | Publication Date |
---|---|
MA31849B1 true MA31849B1 (fr) | 2010-11-01 |
Family
ID=40577704
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA32838A MA31849B1 (fr) | 2007-11-01 | 2010-05-17 | Nouveaux dérivés de pyrimidine |
Country Status (18)
Country | Link |
---|---|
US (1) | US8299086B2 (fr) |
EP (1) | EP2217594B1 (fr) |
JP (1) | JP5517944B2 (fr) |
KR (1) | KR20100092473A (fr) |
CN (1) | CN101970430B (fr) |
AR (1) | AR069146A1 (fr) |
AU (1) | AU2008320374A1 (fr) |
BR (1) | BRPI0818804A2 (fr) |
CA (1) | CA2700917A1 (fr) |
ES (1) | ES2449749T3 (fr) |
IL (1) | IL205425A0 (fr) |
MA (1) | MA31849B1 (fr) |
MX (1) | MX2010004576A (fr) |
NZ (1) | NZ585775A (fr) |
RU (1) | RU2010121969A (fr) |
TW (1) | TW200920746A (fr) |
WO (1) | WO2009057079A2 (fr) |
ZA (1) | ZA201003875B (fr) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2400533T3 (es) * | 2006-09-07 | 2013-04-10 | Actelion Pharmaceuticals Ltd. | Derivados de piridin 4-ilo como agentes inmunomoduladores |
SI2069335T1 (sl) | 2006-09-08 | 2013-04-30 | Actelion Pharmaceuticals Ltd. | Derivati piridin-3-ila kot imunomodulacijska sredstva |
MX2009002781A (es) | 2006-09-15 | 2009-03-30 | Reviva Pharmaceuticals Inc | Sintesis, metodos de uso y composiciones de cicloalquilmetilaminas . |
US8604244B2 (en) | 2010-07-02 | 2013-12-10 | Reviva Pharmaceuticals, Inc. | Compositions, synthesis, and methods of using cycloalkylmethylamine derivatives |
RU2442780C2 (ru) * | 2006-09-21 | 2012-02-20 | Актелион Фармасьютиклз Лтд | Фенильные производные и их применение в качестве иммуномодуляторов |
NZ580454A (en) * | 2007-03-16 | 2011-05-27 | Actelion Pharmaceuticals Ltd | Amino- pyridine derivatives as s1p1 /edg1 receptor agonists |
RU2492168C2 (ru) * | 2007-08-17 | 2013-09-10 | Актелион Фармасьютиклз Лтд | Производные пиридина в качестве модуляторов s1p1/edg1 рецептора |
EP2262799B1 (fr) * | 2008-03-06 | 2012-07-04 | Actelion Pharmaceuticals Ltd. | Composés de pyridine |
EP2262800A1 (fr) * | 2008-03-06 | 2010-12-22 | Actelion Pharmaceuticals Ltd. | Nouveaux dérivés de pyrimidine-pyridine |
SI2252609T1 (sl) * | 2008-03-07 | 2013-07-31 | Actelion Pharmaceuticals Ltd. | Derivati piridin-2-ila kot imunomodulacijska sredstva |
MX2010009645A (es) * | 2008-03-07 | 2010-09-28 | Actelion Pharmaceuticals Ltd | Derivados novedosos de aminometil benceno. |
ES2405054T3 (es) | 2009-01-23 | 2013-05-30 | Bristol-Myers Squibb Company | Derivados de pirazol-1,2,4-oxadiazol como agonistas de esfingosina-1-fosfato |
JP2012515788A (ja) | 2009-01-23 | 2012-07-12 | ブリストル−マイヤーズ スクイブ カンパニー | 自己免疫疾患および炎症性疾患の処置における、s1pアゴニストとしての置換オキサジアゾール誘導体 |
US8354398B2 (en) | 2009-01-23 | 2013-01-15 | Bristol-Myers Squibb Company | Substituted isoxazole compounds |
KR101409131B1 (ko) | 2009-07-16 | 2014-06-17 | 액테리온 파마슈티칼 리미티드 | 피리딘-4-일 유도체 |
US8399451B2 (en) * | 2009-08-07 | 2013-03-19 | Bristol-Myers Squibb Company | Heterocyclic compounds |
WO2011059784A1 (fr) | 2009-10-29 | 2011-05-19 | Bristol-Myers Squibb Company | Composés hétérocycliques tricycliques |
EP2560969B1 (fr) | 2010-04-23 | 2015-08-12 | Bristol-Myers Squibb Company | Amides du 4-(5-isoxazolyl or 5-pyrrazolyl-1,2,4-oxadiazol-3-yl)-acide mandelique comme agonistes du sphingosin-1-phosphate 1 recepteur |
EP2595969B1 (fr) | 2010-07-20 | 2015-04-22 | Bristol-Myers Squibb Company | Composés 3-phényle-1,2,4-oxadiazoles substitués |
US9187437B2 (en) | 2010-09-24 | 2015-11-17 | Bristol-Myers Squibb Company | Substituted oxadiazole compounds |
EP2635573B1 (fr) | 2010-11-03 | 2014-10-01 | Bristol-Myers Squibb Company | Composés hétérocycliques utilisés comme agonistes de s1p1 pour le traitement de maladies auto-immunes et vasculaires |
ES2544086T3 (es) | 2011-01-19 | 2015-08-27 | Actelion Pharmaceuticals Ltd. | Derivados de 2-metoxi-piridin-4-ilo |
CN104039753B (zh) | 2011-12-30 | 2016-09-14 | 雷维瓦药品公司 | 苯基环烷基甲胺衍生物的组合物、合成以及使用方法 |
TWI613182B (zh) | 2013-02-21 | 2018-02-01 | 必治妥美雅史谷比公司 | 雙環化合物 |
PT2970236T (pt) | 2013-03-15 | 2017-11-30 | Idorsia Pharmaceuticals Ltd | Derivados de piridin-4-ilo |
UY36274A (es) | 2014-08-20 | 2016-02-29 | Bristol Myers Squibb Company Una Corporación Del Estado De Delaware | Compuestos bicíclicos sustituidos como agonistas selectivos de la actividad del receptor s1p1 acoplado a la proteína g |
BR112017024785B1 (pt) | 2015-05-20 | 2022-05-17 | Idorsia Pharmaceuticals Ltd | Forma cristalina do composto (s)-3-{4-[5-(2-ciclopentil-6-metoxi-piridin-4-il)-[1,2,4] oxadiazol-3- il]-2-etil-6-metilfenoxi}-propano-1,2-diol, composição farmacêutica, e, uso |
WO2017004609A1 (fr) * | 2015-07-02 | 2017-01-05 | Exelixis, Inc. | Modulateurs thiadiazole de s1p et procédés de fabrication et d'utilisation |
US10633354B2 (en) | 2016-09-02 | 2020-04-28 | Bristol-Myers Squibb Company | Substituted tricyclic heterocyclic compounds |
US11059784B2 (en) | 2017-08-09 | 2021-07-13 | Bristol-Myers Squibb Company | Oxime ether compounds |
US11046646B2 (en) | 2017-08-09 | 2021-06-29 | Bristol-Myers Squibb Company | Alkylphenyl compounds |
Family Cites Families (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1991015583A1 (fr) | 1990-04-05 | 1991-10-17 | The American National Red Cross | Famille de proteines apparentee a une proteine precoce immediate exprimee par des cellules endotheliales humaines durant la differenciation |
JP2002505868A (ja) | 1998-03-09 | 2002-02-26 | スミスクライン・ビーチャム・コーポレイション | ヒトEDG−1cポリヌクレオチドおよびポリペプチドおよびその使用法 |
AU780191B2 (en) | 1999-08-19 | 2005-03-03 | Astrazeneca Ab | Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists |
US6559140B2 (en) * | 2000-03-09 | 2003-05-06 | Abbott Laboratories | Cyclic and bicyclic diamino histamine-3 receptor antagonists |
NZ530772A (en) * | 2001-08-13 | 2006-03-31 | Janssen Pharmaceutica Nv | 2,4,5-trisubstituted thiazolyl derivatives and their antiinflammatory activity |
AU2003207567B2 (en) | 2002-01-18 | 2008-01-24 | Merck Sharp & Dohme Corp. | Edg receptor agonists |
WO2003062248A2 (fr) | 2002-01-18 | 2003-07-31 | Merck & Co., Inc. | N-(benzyl)aminoalkyl carboxylates, phosphinates, phosphonates et tetrazoles en tant qu'agonistes de recepteur edg |
JP4570955B2 (ja) * | 2002-07-09 | 2010-10-27 | バーテクス ファーマスーティカルズ インコーポレイテッド | プロテインキナーゼ阻害活性を持つイミダゾール類 |
WO2004035538A1 (fr) | 2002-10-15 | 2004-04-29 | Merck & Co., Inc. | Procede de fabrication de l'acide azetidine-3-carboxylique |
EP1625123A4 (fr) * | 2003-05-15 | 2007-08-29 | Merck & Co Inc | 3-(2-amino-1-azacyclyl)-5-aryl-1,2,4-oxadiazoles servant d'agonistes du recepteur s1p |
CA2539438A1 (fr) * | 2003-10-01 | 2005-04-14 | Merck And Co., Inc. | 1,2,4-oxadiazoles substitues 3,5-aryle, heteroaryle ou cycloalkyle servant d'agonistes du recepteur s1p |
CN1894225A (zh) | 2003-12-17 | 2007-01-10 | 默克公司 | 作为鞘氨醇1-磷酸(内皮分化基因)受体激动剂的(3,4-二取代)丙酸酯 |
EA014729B1 (ru) | 2004-05-29 | 2011-02-28 | 7ТиЭм ФАРМА А/С | Лиганды crth2 рецептора и их применение |
WO2006047195A2 (fr) | 2004-10-22 | 2006-05-04 | Merck & Co., Inc. | Carboxylates, sulfonates, phosphonates, phosphinates 2-(aryl)azacyclylmethyle et heterocycles utilises comme agonistes des recepteurs s1p |
CA2590939C (fr) * | 2004-12-17 | 2011-10-18 | Amgen Inc. | Composes d'aminopyrimidine et procedes d'utilisation correspondants |
WO2006131336A1 (fr) | 2005-06-08 | 2006-12-14 | Novartis Ag | Oxadiazoles polycycliques ou soxazoles i et leur utilisation comme ligands recepteurs de s1p |
US20090054491A1 (en) | 2005-06-28 | 2009-02-26 | Astrazeneca Ab | Use |
TWI404706B (zh) * | 2006-01-11 | 2013-08-11 | Actelion Pharmaceuticals Ltd | 新穎噻吩衍生物 |
GB0601744D0 (en) * | 2006-01-27 | 2006-03-08 | Novartis Ag | Organic compounds |
WO2007098474A1 (fr) | 2006-02-21 | 2007-08-30 | University Of Virginia Patent Foundation | Composés de phényl-cycloalkyl contenant des structures à anneau hétérocyclique |
ES2400533T3 (es) * | 2006-09-07 | 2013-04-10 | Actelion Pharmaceuticals Ltd. | Derivados de piridin 4-ilo como agentes inmunomoduladores |
SI2069335T1 (sl) * | 2006-09-08 | 2013-04-30 | Actelion Pharmaceuticals Ltd. | Derivati piridin-3-ila kot imunomodulacijska sredstva |
RU2442780C2 (ru) * | 2006-09-21 | 2012-02-20 | Актелион Фармасьютиклз Лтд | Фенильные производные и их применение в качестве иммуномодуляторов |
MX2009006304A (es) | 2006-12-15 | 2009-06-23 | Abbott Lab | Nuevos compuestos de oxadiazol. |
WO2008091967A1 (fr) | 2007-01-26 | 2008-07-31 | Smithkline Beecham Corporation | Composés chimiques |
NZ580454A (en) * | 2007-03-16 | 2011-05-27 | Actelion Pharmaceuticals Ltd | Amino- pyridine derivatives as s1p1 /edg1 receptor agonists |
EP2262799B1 (fr) * | 2008-03-06 | 2012-07-04 | Actelion Pharmaceuticals Ltd. | Composés de pyridine |
MX2010009645A (es) * | 2008-03-07 | 2010-09-28 | Actelion Pharmaceuticals Ltd | Derivados novedosos de aminometil benceno. |
SI2252609T1 (sl) * | 2008-03-07 | 2013-07-31 | Actelion Pharmaceuticals Ltd. | Derivati piridin-2-ila kot imunomodulacijska sredstva |
EP3782991A1 (fr) | 2008-05-14 | 2021-02-24 | The Scripps Research Institute | Nouveaux modulateurs de récepteurs de la sphingosine phosphate |
KR101409131B1 (ko) * | 2009-07-16 | 2014-06-17 | 액테리온 파마슈티칼 리미티드 | 피리딘-4-일 유도체 |
-
2008
- 2008-10-31 KR KR1020107012070A patent/KR20100092473A/ko not_active Application Discontinuation
- 2008-10-31 CA CA2700917A patent/CA2700917A1/fr not_active Abandoned
- 2008-10-31 AU AU2008320374A patent/AU2008320374A1/en not_active Abandoned
- 2008-10-31 MX MX2010004576A patent/MX2010004576A/es not_active Application Discontinuation
- 2008-10-31 BR BRPI0818804 patent/BRPI0818804A2/pt not_active IP Right Cessation
- 2008-10-31 EP EP08846160.3A patent/EP2217594B1/fr not_active Not-in-force
- 2008-10-31 ES ES08846160.3T patent/ES2449749T3/es active Active
- 2008-10-31 NZ NZ585775A patent/NZ585775A/en not_active IP Right Cessation
- 2008-10-31 CN CN2008801140168A patent/CN101970430B/zh not_active Expired - Fee Related
- 2008-10-31 WO PCT/IB2008/054543 patent/WO2009057079A2/fr active Application Filing
- 2008-10-31 JP JP2010531628A patent/JP5517944B2/ja not_active Expired - Fee Related
- 2008-10-31 TW TW097142254A patent/TW200920746A/zh unknown
- 2008-10-31 AR ARP080104783A patent/AR069146A1/es not_active Application Discontinuation
- 2008-10-31 US US12/738,110 patent/US8299086B2/en not_active Expired - Fee Related
- 2008-10-31 RU RU2010121969/04A patent/RU2010121969A/ru not_active Application Discontinuation
-
2010
- 2010-04-29 IL IL205425A patent/IL205425A0/en unknown
- 2010-05-17 MA MA32838A patent/MA31849B1/fr unknown
- 2010-05-31 ZA ZA2010/03875A patent/ZA201003875B/en unknown
Also Published As
Publication number | Publication date |
---|---|
AR069146A1 (es) | 2009-12-30 |
US8299086B2 (en) | 2012-10-30 |
IL205425A0 (en) | 2010-12-30 |
US20100234346A1 (en) | 2010-09-16 |
WO2009057079A3 (fr) | 2009-12-03 |
WO2009057079A2 (fr) | 2009-05-07 |
MX2010004576A (es) | 2010-05-17 |
JP2011502980A (ja) | 2011-01-27 |
ZA201003875B (en) | 2012-08-29 |
EP2217594B1 (fr) | 2014-01-08 |
CN101970430A (zh) | 2011-02-09 |
AU2008320374A1 (en) | 2009-05-07 |
NZ585775A (en) | 2011-12-22 |
TW200920746A (en) | 2009-05-16 |
CA2700917A1 (fr) | 2009-05-07 |
JP5517944B2 (ja) | 2014-06-11 |
CN101970430B (zh) | 2013-05-08 |
KR20100092473A (ko) | 2010-08-20 |
ES2449749T3 (es) | 2014-03-21 |
BRPI0818804A2 (pt) | 2015-04-22 |
RU2010121969A (ru) | 2011-12-10 |
EP2217594A2 (fr) | 2010-08-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA31849B1 (fr) | Nouveaux dérivés de pyrimidine | |
MA31953B1 (fr) | Nouveaux derives du thiophene. | |
MA30765B1 (fr) | Derives innovants du thiophene | |
MA30717B1 (fr) | Derives de pyridin-3-yle en tant qu'agents immunomodulateurs | |
MA30718B1 (fr) | Derives de pyridin-4-yle en tant qu'agents immunomodulateurs. | |
MA33528B1 (fr) | Derives pyridin-4-yliques | |
ATE447568T1 (de) | Neue pyrinderivate | |
TW200700406A (en) | Novel thiophene derivatives | |
TW200716591A (en) | Novel thiophene derivatives | |
TW200716552A (en) | Novel thiophene derivatives | |
MA31290B1 (fr) | Derives d'amino-pyridine comme agonistes du recepteur s1p1/edg1 | |
TW200738670A (en) | Novel thiophene derivatives | |
MY154909A (en) | Novel thiophene derivatives | |
MA31988B1 (fr) | Derives d'aminopyrazole | |
BRPI0514474A (pt) | multiparticulados | |
MA32711B1 (fr) | Pyrrolidine-2-carboxamides substitues | |
TW200942524A (en) | Novel aminomethyl benzene derivatives | |
MY153975A (en) | Pyridine derivatives as s1p1/edg1 receptor modulators | |
MA31906B1 (fr) | Inhibiteurs de la replication du virus de limmunodeficience humaine | |
SG10201809390QA (en) | Modulators of indoleamine 2,3-dioxygenase and methods of using the same | |
ECSP066972A (es) | Profármacos mutuos de glucosamina y glucosamina/anti-inflamatorio, composiciones, y métodos | |
ECSP099413A (es) | COMPUESTOS A BASE DE 4 - fenil - 6 - (2,2,2 - trifluoro - 1 - feniletoxi)pirimidina Y MÉTODOS PARA SU EMPLEO | |
DK1819227T3 (da) | Farmaceutisk formulering af decitabin | |
MA35816B1 (fr) | Dérivés d'aniline, leur préparation et leur application thérapeutique | |
SV2006002089A (es) | Nuevos imidazoles ref. docket 18699 (pc26195a) |